Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 1/20 | 0.30 |
| ▸ | METAP1 | P53582 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15840503 | 0.83 | ALDH1A1 (0.41) | MEN1KMT2A | |
| SCHEMBL1002830 | 0.82 | GABRA1 (0.41) | KMT2A | |
| SCHEMBL808792 | 0.82 | GABRA1 (0.41) | KMT2A | |
| SCHEMBL27608902 | 0.80 | GABRA1 (0.40) | KMT2A | |
| SCHEMBL5589413 | 0.80 | GABRA1 (0.40) | KMT2A | |
| Hydrochloric Acid SCHEMBL1685885 | 0.79 | GABRA1 (0.39) | KMT2A | |
| Hydrochloric Acid SCHEMBL7171618 | 0.79 | GABRA1 (0.39) | KMT2A | |
| Hydrochloric Acid SCHEMBL6909108 | 0.79 | GABRA1 (0.39) | KMT2A | |
| Hydrochloric Acid SCHEMBL6915966 | 0.79 | GABRA1 (0.39) | KMT2A | |
| Hydrochloric Acid SCHEMBL1575632 | 0.79 | GABRA1 (0.39) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9394325-B2 | Enantiopure base-metal catalysts for asymmetric catalysis and bis(imino)pyridine iron alkyl complexes for catalysis | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2016-07-19 | — | — | US | disclosed |
| US-20130079567-A1 | ENANTIOPURE BASE-METAL CATALYSTS FOR ASYMMETRIC CATALYSIS AND BIS(IMINO)PYRIDINE IRON ALKYL COMPLEXES FOR CATALYSIS | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2013-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079567-A1 | ENANTIOPURE BASE-METAL CATALYSTS FOR ASYMMETRIC CATALYSIS AND BIS(IMINO)PYRIDINE IRON ALKYL COMPLEXES FOR CATALYSIS | FECH, PARG, DOHH | METAP2 2097/4885METAP1 2216/4885MEN1 656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.